Pair of discoveries illuminate new paths to flu and anthrax treatments

October 17, 2017, University of California - San Diego
Mouse lung epithelial cells infected with influenza are marked by the expression of NS1 (magenta). These cells augment expression of the Hedgehog target gene, Patched-1 (green). Credit: UC San Diego

Two recent studies led by biologists at the University of California San Diego have set the research groundwork for new avenues to treat influenza and anthrax poisoning.

Published a month apart in PLOS Pathogens, the studies from Professor Ethan Bier's laboratory used a series of experiments to identify key pathways and mechanisms previously unknown or overlooked in the body's defenses.

The first study used fruit flies as an in vivo test system to reveal new evidence about the function of a key influenza protein called NS1, which has evolved to target molecular pathways in the host. Research led by Margery Smelkinson found that NS1 modulates the activitiy of a signaling cascade known as the Hedgehog pathway (so named because fruit fly larvae lacking the Hedgehog gene emerge hairless and resemble tiny hedgehogs).

"Margery's experiments showed that the NS1 protein can alter expression of Hedgehog target genes on its own, without other viral proteins," said Bier, professor and newly named holder of the Tata Chancellor's Endowed Professorship in Cell and Developmental Biology. "The clinical implications of this work are that we might be able use existing drugs that alter Hedgehog signaling to treat influenza infection," said Bier.

"It is remarkable that a defect caused by the influenza NS1 protein in Drosophila led to the discovery of a new role for the NS1 protein in influenza virus-induced pathogenesis," said study coauthor Robert Krug of the University of Texas at Austin. "Margery and Ethan never gave up and eventually overcame the skepticism expressed by other scientists."

The UC San Diego researchers set up collaborations to achieve their findings, including: Krug at the University of Texas at Austin, who generated the influenza virus mutant encoding the mutant NS1 ; and John Teijaro and Michael Oldstone at the Scripps Research Institute, who carried out mammalian pathogenesis studies with the wild-type and mutant influenza virus.

"Another important finding from this study is that we uncovered a mutant form of NS1 that accelerated lethality in flu-infected mice which was linked to stronger activation of Hedgehog signaling," said Smelkinson. "This suggests that reducing Hedgehog signaling during the course of the infection may reduce severity of symptoms. Some Hedgehog signaling reducing agents are currently on the market to treat specific types of cancers while others are in clinical trials. It would be interesting to see if any of these drugs would also be efficacious in treating the flu."

The second study (cover of the latest issue of PLOS Pathogens) describes new findings by Annabel Guichard and her colleagues that could open the door to much needed intervention for treating late-stage anthrax infection.

Anthrax poisonings, as well as cholera infections, work in part by disrupting the normal transport mechanisms of proteins. The researchers analyzed the processes by which proteins that normally bind cells together are blocked by an anthrax toxin named edema factor (EF). This mechanism halts the delivery of the "glue" for key cell sheets—blood vessels for anthrax and intestinal lining for cholera—which results in blood loss-induced shock (anthrax) and acute diarrhea (cholera).

"This study started with experiments in fruit flies, which helped us to identify new molecular pathways affected by these toxins," said Guichard. "It is striking to see how many pathological processes are conserved all the way from insects to humans."

Guichard and her colleagues further identified several molecular inhibitors critical to mediating these effects and tested them in mice with positive results.

"In principle, one could save people suffering from cutaneous late-stage anthrax infections and maybe treat a variety of other similar diseases," said Bier. "These two studies highlight the value of using an integrated multi-systems approach—including fruit flies, mice, and human cells—to discover mechanisms underlying disease processes."

Explore further: Blocking a protein in a critical signaling pathway could offer a new way to combat tumors

Related Stories

Blocking a protein in a critical signaling pathway could offer a new way to combat tumors

August 10, 2016
Cancer drugs that block a cell-signaling pathway called Hedgehog have shown promise in recent years in treating patients with skin cancer, leukemia and other types of tumors. But the available treatments mostly target the ...

Taste bud maintenance in mice requires Hedgehog signaling

November 28, 2016
Disruptions in the Hedgehog signaling pathway can interfere with taste bud maintenance in mice, potentially explaining why some cancer patients experience a loss of taste during treatment with Hedgehog-blocking drugs. Charlotte ...

Anthrax spores use RNA coat to mislead immune system

April 11, 2017
Researchers from Harvard Medical School have discovered that the body's immune system initially detects the presence of anthrax spores by recognizing RNA molecules that coat the spores' surface. But this prompts an unfavorable ...

Scientists find cause of facial widening defects

November 1, 2016
Widening across the forehead and nose occurs when loss of cilia at the surface of the cells disrupts internal signaling and causes two GLI proteins to stop repressing midfacial growth. Ching-Fang Chang and Samantha Brugmann ...

Key regulator of bone development identified

December 8, 2016
Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes—a condition known as brachydactyly. The discovery was made by researchers at Penn State ...

Recommended for you

New inflammation inhibitor discovered

November 16, 2018
A multidisciplinary team of researchers led from Karolinska Institutet in Sweden have developed an anti-inflammatory drug molecule with a new mechanism of action. By inhibiting a certain protein, the researchers were able ...

Infants born to obese mothers risk developing liver disease, obesity

November 16, 2018
Infant gut microbes altered by their mother's obesity can cause inflammation and other major changes within the baby, increasing the risk of obesity and non-alcoholic fatty liver disease later in life, according to researchers ...

New study shows NKT cell subsets play a large role in the advancement of NAFLD

November 16, 2018
Since 2015 it has been known that the gut microbiota could have a direct impact on nonalcoholic fatty liver disease (NAFLD), which affects up to 12% of adults and is a leading cause of chronic liver disease. In the November ...

Gut hormone and brown fat interact to tell the brain it's time to stop eating

November 15, 2018
Researchers from Germany and Finland have shown that so-called "brown fat" interacts with the gut hormone secretin in mice to relay nutritional signals about fullness to the brain during a meal. The study, appearing November ...

Brain, muscle cells found lurking in kidney organoids grown in lab

November 15, 2018
Scientists hoping to develop better treatments for kidney disease have turned their attention to growing clusters of kidney cells in the lab. One day, so-called organoids—grown from human stem cells—may help repair damaged ...

How the Tasmanian devil inspired researchers to create 'safe cell' therapies

November 15, 2018
A contagious facial cancer that has ravaged Tasmanian devils in southern Australia isn't the first place one would look to find the key to advancing cell therapies in humans.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.